Companion Vaccines for CAR T-cell Therapy: Applying Basic Immunology to Enhance Therapeutic Efficacy
Author:
Open Access
- 29 June 2020
- journal article
- editorial
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 12 (15) , 1359-1362
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- An RNA vaccine drives expansion and efficacy of claudin-CAR-T cells against solid tumorsScience, 2020
- Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptorScience, 2019
- A Phase II Study of Tumor-infiltrating Lymphocyte Therapy for Human Papillomavirus–associated Epithelial CancersClinical Cancer Research, 2019
- Antitumor activity of CAR-T cells targeting the intracellular oncoprotein WT1 can be enhanced by vaccinationBlood, 2018
- Two-Factor Authentication for Type 2 ImmunityImmunity, 2018
- International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy studyThe Lancet, 2018
- First-Ever CAR T-cell Therapy Approved in U.S.Cancer Discovery, 2017
- Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 studyThe Lancet Oncology, 2017
- A Perspective on the Role of Computational Models in ImmunologyAnnual Review of Immunology, 2017
- How many TCR clonotypes does a body maintain?Journal of Theoretical Biology, 2016